Introduction
A surgical site infection is defi ned by the Centers for Disease Control and Prevention's (CDC's) National Healthcare Safety Network as an infection of the surgical site following a surgical procedure. The surgical procedure must involve an incision through skin or mucous membrane. Surgical site infections following surgical procedures are classifi ed as superfi cial incisional, deep incisional, or organ/space, depending upon the tissue or body part involved (Association for Professionals in Infection Control and Epidemiology [APIC] , 2010, p. 17 ) (Level II).
Surgical site infection is recognized as one of the most prevalent healthcare-associated infections (Mangrum et al., Horan, T., Pearson, M., Silver, L., & Jarvis, W., 1999 ) (Level I). Up to 355,500 surgical patients develop SSI after orthopaedic surgery each year ( Eislet, 2009 ) (Level I). Surgical site infections play a major role in increasing morbidity and mortality rates, prolonging hospitalizations, and increasing hospital readmissions, in addition to contributing to rising healthcare costs ( Bachoura et al., 2011 ) (Level II) .
To reduce the risk of SSIs, a systematic but realistic approach must be applied with the awareness that this risk is infl uenced by the presence of modifi able and nonmodifi able factors ( Reyes & Chang, 2011 ) (Level I). Modifi able risk factors include surgical technique and the measures of infection prevention that are utilized. Nonmodifi able risk factors are the presence of patient comorbidities, the type of procedure performed (emergent vs nonemergent), and the presence of wound contamination prior to surgery ( Mu, Edwards, Horan, Berrios-Torres, & Fridkin, 2011 ) (Level IV). Other nonmodifi able risk factors that highly infl uence the development of SSI following skeletal trauma include the site of injury, the number of operations required to effectively address the injury, the utilization of a drain, and the patient being a methicillin-resistant Staphylococcus aureus (MRSA) carrier ( Bachoura et al., 2011 ) (Level II).
Purpose
The purpose for the Surgical Site Infection Prevention Clinical Practice Guideline is to educate staff in promoting a multifaceted approach to prevent all orthopaedic surgery-related infections. A consistent implementation of practices related to preoperative surgical site preparation, intraoperative as well as postoperative care would serve to improve outcomes.
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Rationale for Guideline
Because of increasing prevalence, extent of injury, rising healthcare costs pertaining to SSIs, and the increasing incidence of MRSA-related SSIs, prophylaxis pertaining to SSIs has become a national priority ( Evans, 2009 ) (Level I). The incidence of SSIs may be decreased and the extent of injury minimized by utilizing evidencebased SSI prophylaxis measures ( Hall, 2007 ) 
The Surgical Care Improvement Project (SCIP) is a national partnership that was developed in 2003 by the Centers for Medicare and Medicaid Services, the CDC, and various organizations committed to improving the safety of surgical care through the reduction of postoperative complications by utilizing evidence-based core measures. The SCIP was developed as a result of core measures pertaining to the prevention of surgical infections in the hospital setting that were introduced by The Joint Commission in 2003. SCIP Infection (INF) milestones for infection prevention include the following:
• SCIP INF 1a : Prophylactic antibiotic received within 1-hour prior to surgical incision ( Evans, 2009 ) (Level I);
• failure to obliterate dead space; • tissue trauma; and • postoperative wound care ( Mangram, Horan, Pearson, Silver, & Jarvis, 1999 ) (Level I).
A variety of patient or host and procedure-associated factors also appear to be related to an increased risk of infection following orthopaedic surgery. Host-specifi c SSI risk factors include the following: 1. obesity; 2. current smoking; 3. hematocrit < 36; 4. elevated preoperative or postoperative serum glucose; 5. diabetes; 6. chronic steroid use 7. advanced age 8. renal failure 9. low serum albumin level 10. patient being a carrier of MRSA; 11. male gender; 12. rheumatoid arthritis; 13. The American Society of Anesthesiologists (ASA) Score of 3 or greater; 14. disseminated cancer; and 15. admission from a healthcare facility.
Procedure specifi c SSI risk factors include the following:
• estimated blood loss of greater than 1 L; • longer procedure time;
• suboptimal timing of prophylactic antibiotic; • two or more residents participating in the procedure; • prolonged wound drainage; • spinal procedure via the posterior or the anterior/ posterior approach; • previous infection at the site; and • low volume of procedures performed by the surgeon or low volume performed at the hospital ( APIC, 2010, p. 12 ) (Level II).
Defi nition of the Problem
Surgical site infections can lead to compromised wound healing and failure of components and hardware, in addition to increased medical costs, morbidity, and mortality ( Evans, 2009 ) 
Goal of Clinical Practice Guideline
Identifi cation of evidence-based prevention measures pertaining to SSIs will provide orthopaedic nurses with the knowledge base needed to effectively deliver highquality, continuity of care among patients undergoing surgery of the musculoskeletal system.
Assessment of Scientifi c Evidence
The CDC guidelines for reducing the transmission of SSIs include utilizing contact precautions for patients with known or suspected infections, employing appropriate hand hygiene measures, performing effective environmental cleaning, and following the SCIP measures ( Hall, 2007 ) (Level I). Studies have also been conducted regarding the utilization of patient-centered modalities to decrease the incidence of SSIs. These modalities include, but are not limited to nasal swabbing, preoperative skin cleansing, preoperative hair removal, perioperative antibiotic timing, and specifi c postoperative care measures ( Standiford & Aziz, 2005 ) (Level I). 
NURSING DIAGNOSIS

Utilization of Clinical Quality Indicators
Nursing Interventions and Expected Outcomes
The spread of infectious disease can be prevented by maintaining contact precautions for patients with an infection that is present or suspected. This includes, but is not limited to, good hand-washing practices, utilizing private patient rooms along with contact precautions, using personal protective equipment, and maintaining sterility when performing all sterile and aseptic procedures. Soap and water are the most effective means of removing infectious organisms from hands/fi ngers.
Hand antiseptics should be used as directed ( Standiford & Aziz, 2005 ) (Level I).
Before entering the operating room, traditional or dry scrubbing of hands must take place to help prevent the development of SSI. There is no increased risk for SSI with the use of dry scrubbing versus traditional scrubbing ( Parienti, Thibon, & Heller, 2002 ) (Level I). • Ask the patient to describe his or her living environment ( Bachoura et al., 2011 ) (Level II). • Observe very closely those patients with nonmodifi able risk factors that may be at increased risk for SSI postoperatively ( Prokuski, 2008 ) (Level I).
NURSING ASSESSMENT PERTAINING TO PATIENT CARE
Patient Care Management
DETERMINE WOUND CLASSIFICATION
The CDC recommends assessing surgical wounds and determining the probability of SSI by utilizing a classifi cation that consists of four types of surgical wounds ( AORN, 2011 ) .
Clean wounds (Class I) :
Uninfected operative wounds where no infl ammation is present and no signs of infection. These wounds are primarily closed and are able to be drained with a closed wound drainage system. An example of a clean wound is a total joint replacement. 
Preoperative Patient Skin Cleansing
• Chlorhexidine gluconate-containing products require several applications to attain maximum antimicrobial benefi t; so repeated antiseptic showers are usually indicated preoperatively (preferably the evening before surgery and the morning of surgery). If advanced notice prior to surgery, cleansing can be recommended each day up to approximately 5 days before surgery ) (Level I).
that may lead to seeding of bacteria and a deep joint infection ( Kaar, Bogoch, & Devlin, 2000 ) (Level II 
INTRAOPERATIVE CARE
Surgical Hand Antisepsis
Surgical hand antisepsis is a crucial factor in preventing SSIs. It is performed before donning sterile gloves. The purpose of a surgical hand antisepsis is to reduce transient and resident microorganisms on the hands and maintain the bacterial level below baseline, as this may reduce hospital-acquired infections ( APIC, 2010 ) (Level II). In the United States, a standardized surgical hand scrub or rub should be performed, using either an antimicrobial surgical agent or an alcohol-based antiseptic surgical hand rub with documented persistent and cumulative activity that has met the U.S. Food and Drug Administration regulatory requirements for surgical hand antisepsis.
Skin Antisepsis
The selection of the preoperative skin antiseptic agent should be based on patient assessment for any allergy or sensitivity to skin preparation agents. Qualities the preoperative antiseptic agent should possess are (APIC, 2011) (Level II) as follows:
• signifi cantly reduce microorganisms on intact skin; • contain a nonirritating antimicrobial preparation; • be broad spectrum and fast acting; and • have a persistent effect.
After a patient has been placed on the operating room table, the surgical site should be prepared by painting it with a povidone-iodine, iodine with alcohol base, or chlorhexidine solution. Chlorhexidine has been proven to be more effective in preventing SSIs when compared to iodine-based solutions ( Digison, 2007 ) (Level II).
Antibiotic Prophylaxis
• Many facilities include antibiotic prophylaxis as a routine part of the surgical time-out. An important consideration in total knee replacements is the infusion of the antibiotic prior to infl ation of the tourniquet (APIC, 2011) (Level II).
Preoperative Hair Removal
• If hair removal is required in the perioperative setting, it should be removed just prior to the surgical procedure. It is recommended that hair removal take place with electric clippers ( Hall, 2007 ) (Level I).
Blood Transfusions
• Autologous and allogeneic blood transfusions intraoperatively and postoperatively may slightly increase the risk for SSI. The risk is greater with allogeneic than autologous ( Kendall, Weir, Aspinall, Henderson, & Rosson, 2000 ) (Level III).
IV Antibiotic Timing ( Hall, 2007 ) (Level I) • Initiate up to 60 minutes before incision: cefazolin, cefuroxime, clindamycin. • Initiate up to 120 minutes before incision:
vancomycin. • Infusion completed a minimum of 10 minutes prior to tourniquet infl ation.
Duration of Antimicrobial Use
• Single preoperative dose ( Hall, 2007 ) (Level I).
• Redose antimicrobial intraoperatively when procedure exceeds one to two times the antibiotic's half-life or when there is signifi cant blood loss ( Prokuski, 2008 ) (Level I). • When using postoperative doses, discontinue within 24 hours after closure of the incision ( Hall, 2007 ) (Level I). • Patients with a higher than normal body mass index may require higher dosages of antimicrobial therapy.
Preoperative Issues
• Whenever possible, identify and treat all infections remote to the surgical site before elective surgery and postpone elective surgery on patients with remote site infections until infection has resolved ) (Level I). • Consider checking hemoglobin A1C levels in patients with diabetes. Adequately control serum blood glucose levels in patients with diabetes and particularly avoid hyperglycemia during perioperative phase ) (Level I). • Adequately control serum blood glucose levels of less than 180 mg/dl in all diabetic patients and particularly avoid hyperglycemia perioperatively. Hyperglycemia reduces the body's natural resistance to infection. "Diabetes has been associated with an increased risk of surgical site infections in several orthopaedic disciplines. While this socalled diabetic disadvantage may be due, in part, to the impact of the disease on a patient's biology and physiology, it is more likely that the acute effects of perioperative hyperglycemia are even more detrimental" ( Evans, 2009 , p. 4 
Disinfection of Noncritical Items
• Noncritical items include items that come in contact with intact skin. Examples of these items would include continuous passive motion machines, ice therapy packs, blood pressure cuffs, and so forth (AORN, 2010) (Level II). • These noncritical items should be cleaned at the point of use with an immediate-level or low-level disinfectant such as alcohols, sodium, hypochlorite, phenolic solutions, or ammonium solutions (AORN, 2010) (Level II).
Nursing Responsibilities With Prophylaxis Antibacterial Therapy
• Assess the patient's allergy history before beginning IV antibacterial therapy or applying topical antiseptic agents ( AORN, 2011 ) (Level II). • Practice strict hand washing and contamination precautions before handling each patient's IV site ) (Level I). • Monitor infusion/injection site for signs of extravasation-pain, edema, and drainage ( AORN, 2011 ) (Level II). • Ensure that IV antibiotics are given on time as ordered if the patient is receiving postoperative inpatient antibiotic IV therapy ( AORN, 2011 ) (Level II). • Monitor closely for hypersensitivity reaction during and after each dose ( AORN, 2011 ) (Level II). • Monitor for and instruct the patient to report severe diarrhea ( Standiford & Aziz, 2005 ) (Level I). • Monitor for and instruct the patient to report signs of renal impairment-blood urea nitrogen and creatinine intake and output and urine color ( Horan et al., 1992 ) (Level III). • Monitor and instruct the patient to report any side effects specifi c to particular antibacterial agent ( Horan et al., 1992 ) (Level III). • Ensure that IV antibiotics are discontinued within 24 hours after surgical end time ( Evans, 2009 ) (Level I).
PATIENT EDUCATION
Preoperative
• Encourage tobacco cessation. At a minimum, instruct patients to abstain from smoking cigarettes, cigars, pipes, or any other form of tobacco consumption for at least 30 days before an elective
Air Quality
• The quality of air entering the operating room should be carefully controlled by keeping operating room doors closed except as needed for passage of equipment, personnel, and the patient (AORN, 2011) (Level II).
Traffi c Patterns
• Limit the number of personnel entering operating room to necessary personnel only (AORN, 2010) (Level II).
Maintain Normothermia to Avoid Hypothermia
• Hypothermia is defi ned as a core temperature less than 96.8 ° F ( AORN, 2011 ) (Level II).
Sterilization of Surgical Instruments
• Sterilize all surgical instruments according to institutional guidelines. • Perform fl ash sterilization only in emergent situations when instruments will be used immediately. Do not use fl ash sterilization for reasons of convenience, as an alternative to purchasing additional instrument sets, or to save time (AORN, 2010) (Level II).
POSTOPERATIVE CARE
Postoperative Incisional Care
• Protect an incision that has been closed primarily with a sterile dressing for 24-48 hours postoperatively ) (Level I). • Perform hand hygiene before and after dressing changes and any contact with the surgical site ) (Level I). • When an incision dressing must be changed, use sterile technique ) (Level I). • Educate the patient and family regarding proper incision care, symptoms of SSI, and the need to report such symptoms (Level I).
Postoperative Skeletal Pin Care
• Be aware that pins located in soft tissue area are at greater risk for infection ( Holmes & Brown, 2005 ) (Level II). • After the fi rst 48-72 hours following skeletal pin placement, pin site care should be done daily or weekly ( Holmes & Brown, 2005 ) (Level II). • Chlorhexidine 2 mg/mL solution is considered to be the most effective cleansing solution for skeletal pin site care ( Holmes & Brown, 2005 ) (Level  II) . Saline should be used if chlorhexidine solution is contraindicated according to the Royal College of Nursing (2011). (Level V). • Strict hand washing before and after skeletal pin site care should always take place. Note : Follow your facility's specifi c policy and procedure pertaining to skeletal pin care.
